Epigenetics, nervous system tumors, and cancer stem cells

Irfan A. Qureshi, Mark F. Mehler

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Recent advances have begun to elucidate how epigenetic regulatory mechanisms are responsible for establishing and maintaining cell identity during development and adult life and how the disruption of these processes is, not surprisingly, one of the hallmarks of cancer. In this review, we describe the major epigenetic mechanisms (i.e., DNA methylation, histone and chromatin modification, non-coding RNA deployment, RNA editing, and nuclear reorganization) and discuss the broad spectrum of epigenetic alterations that have been uncovered in pediatric and adult nervous system tumors. We also highlight emerging evidence that suggests epigenetic deregulation is a characteristic feature of so-called cancer stem cells (CSCs), which are thought to be present in a range of nervous system tumors and responsible for tumor maintenance, progression, treatment resistance, and recurrence. We believe that better understanding how epigenetic mechanisms operate in neural cells and identifying the etiologies and consequences of epigenetic deregulation in tumor cells and CSCs, in particular, are likely to promote the development of enhanced molecular diagnostics and more targeted and effective therapeutic agents for treating recalcitrant nervous system tumors.

Original languageEnglish (US)
Pages (from-to)3525-3556
Number of pages32
JournalCancers
Volume3
Issue number3
DOIs
StatePublished - Sep 2011

Fingerprint

Nervous System Neoplasms
Neoplastic Stem Cells
Epigenomics
Histone Code
RNA Editing
Neoplasms
Untranslated RNA
Molecular Pathology
DNA Methylation
Chromatin
Maintenance
Pediatrics
Recurrence

Keywords

  • Cancer
  • Cancer stem cell
  • Chromatin
  • Corest
  • Epigenetic
  • Glioblastoma multiforme
  • Nervous system tumor
  • Non-coding RNA
  • REST

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Epigenetics, nervous system tumors, and cancer stem cells. / Qureshi, Irfan A.; Mehler, Mark F.

In: Cancers, Vol. 3, No. 3, 09.2011, p. 3525-3556.

Research output: Contribution to journalArticle

Qureshi, Irfan A. ; Mehler, Mark F. / Epigenetics, nervous system tumors, and cancer stem cells. In: Cancers. 2011 ; Vol. 3, No. 3. pp. 3525-3556.
@article{e6c652de40b34238bfb68ae2c7a8407c,
title = "Epigenetics, nervous system tumors, and cancer stem cells",
abstract = "Recent advances have begun to elucidate how epigenetic regulatory mechanisms are responsible for establishing and maintaining cell identity during development and adult life and how the disruption of these processes is, not surprisingly, one of the hallmarks of cancer. In this review, we describe the major epigenetic mechanisms (i.e., DNA methylation, histone and chromatin modification, non-coding RNA deployment, RNA editing, and nuclear reorganization) and discuss the broad spectrum of epigenetic alterations that have been uncovered in pediatric and adult nervous system tumors. We also highlight emerging evidence that suggests epigenetic deregulation is a characteristic feature of so-called cancer stem cells (CSCs), which are thought to be present in a range of nervous system tumors and responsible for tumor maintenance, progression, treatment resistance, and recurrence. We believe that better understanding how epigenetic mechanisms operate in neural cells and identifying the etiologies and consequences of epigenetic deregulation in tumor cells and CSCs, in particular, are likely to promote the development of enhanced molecular diagnostics and more targeted and effective therapeutic agents for treating recalcitrant nervous system tumors.",
keywords = "Cancer, Cancer stem cell, Chromatin, Corest, Epigenetic, Glioblastoma multiforme, Nervous system tumor, Non-coding RNA, REST",
author = "Qureshi, {Irfan A.} and Mehler, {Mark F.}",
year = "2011",
month = "9",
doi = "10.3390/cancers3033525",
language = "English (US)",
volume = "3",
pages = "3525--3556",
journal = "Cancers",
issn = "2072-6694",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "3",

}

TY - JOUR

T1 - Epigenetics, nervous system tumors, and cancer stem cells

AU - Qureshi, Irfan A.

AU - Mehler, Mark F.

PY - 2011/9

Y1 - 2011/9

N2 - Recent advances have begun to elucidate how epigenetic regulatory mechanisms are responsible for establishing and maintaining cell identity during development and adult life and how the disruption of these processes is, not surprisingly, one of the hallmarks of cancer. In this review, we describe the major epigenetic mechanisms (i.e., DNA methylation, histone and chromatin modification, non-coding RNA deployment, RNA editing, and nuclear reorganization) and discuss the broad spectrum of epigenetic alterations that have been uncovered in pediatric and adult nervous system tumors. We also highlight emerging evidence that suggests epigenetic deregulation is a characteristic feature of so-called cancer stem cells (CSCs), which are thought to be present in a range of nervous system tumors and responsible for tumor maintenance, progression, treatment resistance, and recurrence. We believe that better understanding how epigenetic mechanisms operate in neural cells and identifying the etiologies and consequences of epigenetic deregulation in tumor cells and CSCs, in particular, are likely to promote the development of enhanced molecular diagnostics and more targeted and effective therapeutic agents for treating recalcitrant nervous system tumors.

AB - Recent advances have begun to elucidate how epigenetic regulatory mechanisms are responsible for establishing and maintaining cell identity during development and adult life and how the disruption of these processes is, not surprisingly, one of the hallmarks of cancer. In this review, we describe the major epigenetic mechanisms (i.e., DNA methylation, histone and chromatin modification, non-coding RNA deployment, RNA editing, and nuclear reorganization) and discuss the broad spectrum of epigenetic alterations that have been uncovered in pediatric and adult nervous system tumors. We also highlight emerging evidence that suggests epigenetic deregulation is a characteristic feature of so-called cancer stem cells (CSCs), which are thought to be present in a range of nervous system tumors and responsible for tumor maintenance, progression, treatment resistance, and recurrence. We believe that better understanding how epigenetic mechanisms operate in neural cells and identifying the etiologies and consequences of epigenetic deregulation in tumor cells and CSCs, in particular, are likely to promote the development of enhanced molecular diagnostics and more targeted and effective therapeutic agents for treating recalcitrant nervous system tumors.

KW - Cancer

KW - Cancer stem cell

KW - Chromatin

KW - Corest

KW - Epigenetic

KW - Glioblastoma multiforme

KW - Nervous system tumor

KW - Non-coding RNA

KW - REST

UR - http://www.scopus.com/inward/record.url?scp=80053214795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053214795&partnerID=8YFLogxK

U2 - 10.3390/cancers3033525

DO - 10.3390/cancers3033525

M3 - Article

C2 - 24212967

AN - SCOPUS:80053214795

VL - 3

SP - 3525

EP - 3556

JO - Cancers

JF - Cancers

SN - 2072-6694

IS - 3

ER -